Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

Conditions: Advanced Hepatocellular Carcinoma; Anti-PD1/PDL1 Antibody; Bevacizumab Interventions: Procedure: Locoregional therapy; Drug: Bevacizumab; Drug: Atezolizumab; Drug: Tislelizumab; Drug: Toripalimab; Drug: Sintilimab; Drug: Camrelizumab Sponsors: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials